Abstract

Objectives

Community-onset bloodstream infections (BSIs) caused by carbapenemase-producing Enterobacter cloacae complex (ECC) species are increasing internationally. This observation suggests that ECC are emerging pathogens, requiring for detailed understanding on their genomic epidemiology including transmission dynamics and antimicrobial resistance profiles.

Patients and methods

We performed WGS on 79 Enterobacter spp. isolated from the patients with clinically significant BSIs and admitted to emergency department of a major tertiary hospital in Nepal between April 2016 and October 2017.

Results

We identified 5 species and 13 STs of ECC. Enterobacter xiangfangensis ST171, one of the globally emerging carbapenem resistant ECC clones with epidemic potential, was the most prevalent (42%). Phylogenetic analysis showed a large (>19 400 SNPs) core genome SNP distance across major STs, which was minimal (<30 SNPs) among the isolates of each prevalent ST, suggesting the relatively recent importation of major STs followed by local clonal expansions. Genomic evidence for resistance to all major antimicrobial classes except for colistin and macrolides was detected. A limited number of isolates also carried blaNDM-1 (n = 2) and blaOXA-48 (n = 1) carbapenemase genes. Virulence factors encoding siderophores (24%), T6SSD (25%) and fimbriae (54%) were detected.

Conclusions

Our study highlighted that MDR ECC clones are important pathogens of BSIs in community. Though of low prevalence, carbapenem resistance observed in our ECC isolates raised concern about further community dissemination, underscoring the need for community surveillance to identify MDR ECC clones with epidemic potential.

Details

Title
Genomic epidemiology, antimicrobial resistance and virulence factors of Enterobacter cloacae complex causing potential community-onset bloodstream infections in a tertiary care hospital of Nepal
Author
Manandhar, Sulochana 1 ; Nguyen, Quynh 2 ; To Nguyen Thi Nguyen 2 ; Duy Thanh Pham 3 ; Rabaa, Maia A 3 ; Dongol, Sabina 1 ; Basnyat, Buddha 1 ; Dixit, Sameer M 4 ; Baker, Stephen 5 ; Karkey, Abhilasha 1 

 Oxford University Clinical Research Unit, Patan Academy of Health Sciences , Kathmandu, Nepal 
 Oxford University Clinical Research Unit, Hospital for tropical diseases , Ho Chi Minh City, Vietnam 
 Centre for Tropical Medicine and Global Health, Medical sciences division, Nuffield Department of Medicine, University of Oxford , Oxford, UK 
 Center for Molecular Dynamics Nepal , Kathmandu, Nepal 
 Department of Medicine, University of Cambridge, School of Clinical Medicine, Cambridge Biomedical Campus , Cambridge, UK 
Publication year
2022
Publication date
Jun 2022
Publisher
Oxford University Press
e-ISSN
26321823
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3170008158
Copyright
© The Author(s) 2022. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy. This work is published under https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.